Lv41
570 积分 2024-04-17 加入
What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015
19天前
已完结
Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method
1个月前
已完结
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
1个月前
已完结
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
3个月前
已完结
Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective
3个月前
已完结
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors
3个月前
已完结
Efficacy and Safety Exposure–Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma
4个月前
已完结
Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pH
6个月前
已完结
Evaluation of Normalization Methods To Predict CYP3A4 Induction in Six Fully Characterized Cryopreserved Human Hepatocyte Preparations and HepaRG Cells
7个月前
已完结
Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or Induction
7个月前
已完结
皖公网安备34019202002308
